Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

Abhishek A. Mangaonkar, David M. Swoboda, Giacomo Coltro, Terra L. Lasho, Paul J. Novotny, Prateek Pophali, Ryan M. Carr, Moritz Binder, Christy M. Finke, Naseema Gangat, Aref Al-Kali, Kebede H. Begna, Kaaren K. Reichard, Rhett P. Ketterling, Najla H. Al Ali, Pardis Vafaii, Ling Zhang, Eric Padron, Chetasi Talati, Mrinal M. Patnaik

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)656-661
Number of pages6
JournalLeukemia
Volume34
Issue number2
DOIs
StatePublished - Feb 1 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Mangaonkar, A. A., Swoboda, D. M., Coltro, G., Lasho, T. L., Novotny, P. J., Pophali, P., Carr, R. M., Binder, M., Finke, C. M., Gangat, N., Al-Kali, A., Begna, K. H., Reichard, K. K., Ketterling, R. P., Al Ali, N. H., Vafaii, P., Zhang, L., Padron, E., Talati, C., & Patnaik, M. M. (2020). Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients. Leukemia, 34(2), 656-661. https://doi.org/10.1038/s41375-019-0574-x